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Abstract  
BACKGROUND: Antibiotics (abx) constitute the most prescribed therapeutic agent in the world. There is little 
data regarding antibiotic consumption by young children in Albania. 
AIM: This study aims to evaluate antibiotic prescription in children in quantitative and qualitative terms, and 
therefore, propose recommendations to improve overall clinical outcomes. 
METHODS: A retrospective, cross-sectional drug utilisation study was conducted based on unreimbursed 
prescriptions collected in 25 pharmacies, randomly selected within the district of Tirana, during the period 
beginning December 2015 to January 2016. They contain at least one antibacterial therapeutic agent prescribed 
for children 0-15 years old, for systemic use. The data were analysed using SPSS 20. 
RESULTS: A group of 904 prescriptions meet inclusion criteria, 54.1% patient were female, and 45.9% were 
male. The most exposed age group were 2-6 years old. The most common diagnosis was respiratory tract 
infections: bronchitis (59.2%), tonsillitis (17%) followed by bronchopneumonia (9.6%). The most prescribed 
antibiotic classes are Penicillins (33%), Cephalosporins (33.2%) and Macrolides (21,5%). Amoxicillin (19.4%), 
Azithromycin (14.7%), the combination of Amoxicillin and Clavulanic acid (13.5%) and Cefaclor (11.7%) were the 
most commonly prescribed. We observed short duration therapies, with a mean duration of 5.21 days and in 17.4 
% of cases with a duration of ≤ 2 days. 
CONCLUSIONS: We observed a large use of broad-spectrum antibiotics for common respiratory tract infection in 
children less than 6 years old. We would recommend the creation of an electronic database of patient’s record in 
order to monitor the quality of prescription and education of the healthcare professionals and patient of risks 
related to antibiotic resistance. 
 
 
 
 
 
Introduction 
 
Antibiotics (abx) constitute the most 
prescribed therapeutic agent in the world [1]. Their 
use has become prolific worldwide, and the rate of 
prescriptions grown along with [2] [3]. Preschool 
children are the primary recipients of this medication. 
[4]. Differences in antibiotic prescription in quantitative 
and qualitative terms, caries greatly from region to 
region, country to country [5]. Overuse and misuse of 
antibiotics have been proven to be the primary cause 
of antibiotic resistance in patients [6]. It is estimated 
that almost 50% of antibiotics prescribed for children 
by primary care physicians are unnecessary [7]. In the 
USA, almost three-quarters of all antibiotics are 
prescribed for acute respiratory infections, and 44% of 
children with common colds were reported to be 
treated with antibiotics [8] [9]. In Canada, 74% of 
preschool children seeking care for respiratory 
infections received antibiotic prescriptions [10]. 
Prescribing broad-spectrum antibiotics, instead of the 
narrow spectrum (when appropriate) is also a 
common type of inappropriate usage [11]. There is 
little data regarding antibiotic consumption by young 
children in Albania.  
This study aims to evaluate antibiotic 
prescription in children in quantitative and qualitative 
terms and to, therefore, propose recommendations 
and counter-measures to improve overall clinical 
outcomes.  
Public Health 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2                                                                                                                                                                                                    https://www.id-press.eu/mjms/index 
 
Patients and Methods 
 
A retrospective, cross-sectional drug 
utilisation study was conducted based on 
unreimbursed prescriptions collected in 25 
pharmacies, randomly selected within the district of 
Tirana. Drugs were prescribed by physicians and 
dispersed by pharmacies during the period beginning 
December 2015 to January 2016. They contain at 
least one antibacterial therapeutic agent prescribed 
for children 0-15 years old, for systemic use. The aim 
of this study is: to evaluate the most prescribed 
antibiotics; to discover the most common diagnosis 
they are prescribed for and the mean duration of 
therapy for each diagnosis; and finally, to compare 
possible similar patterns of prescription dissemination 
with other countries. To define each drug, we referred 
to the Anatomical Therapeutic Chemical Classification 
System (ATC). According to this system, antibiotics 
for systemic use are defined as the J01 main 
therapeutic group [12]. The data were analysed using 
SPSS 20. 
 
 
Results 
 
We collected a total number of 904 
prescriptions, 54.1% patient were female, and 45.9% 
were male. According to children age, the most 
exposed age group were 2-6 years old, and preschool 
children (≤ 6 years old) represent 2/3 of total 
prescription.  
 
Figure 1: Prescription of antibiotics among age groups 
 
Antibiotic therapy was given to children for 1 -
10 days, with a mean therapy duration of 5.21 days. In 
17.4% of cases, antibiotic are given to children for ≤ 2 
days. Most common diagnosis for prescribing an 
antibiotic was respiratory tract infections: bronchitis 
(59.2%), tonsillitis (17%) followed by 
bronchopneumonia (9.6%).  
Table 1: Diagnosis for prescribing an antibiotic and mean 
duration of therapy 
Diagnose % Mean 
Duration 
(days) 
Std. 
Deviation 
95% Confidence Interval for 
Mean 
Lower 
Bound 
UpperBound 
Tonsilitis 17 5.15 2.309 4.78 5.52 
Bronchitis 59.2 5.22 2.291 5.02 5.41 
Bronchopneumonia 9.6 5.63 1.472 5.32 5.95 
Gastroenteritis 4.1 5.05 2.438 4.24 5.87 
Otitis 2 5.89 1.875 4.96 6.82 
Urinary tract infection 0.7 6.83 1.941 4.80 8.87 
Synositis 3.4 5.35 2.039 4.60 6.00 
Dental infection 2.5 4.17 2.188 3.23 5.12 
Parasitic infection 1.4 3.00 2.000 1.79 4.21 
 
The most prescribed antibiotic classes are 
Penicillins (33%), Cephalosporins (33.2%) and 
Macrolides (21.5%) followed by Aminoglycosides with 
3.3% of cases.  
Table 2: Systemic antibiotics prescription 
Chemical group Drug % 
J01C Penicillins J01CA04 Amoxicillin 19.4 
J01CR02 Amoxicillin and Clavulanic acid 13.5 
J01DB First-generation 
cephalosporins 
J01DB01 Cefalexin 5 
J01DB04 Cefazolin 3 
J01DC Second-generation 
cephalosporins 
J01DC02 Cefuroxime 2.2 
J01DC04 Cefaclor 11.7 
J01DD Third-generation 
cephalosporins 
J01DD02 Ceftazidime 0.2 
J01DD04 Ceftriaxone 6.4 
J01DD08 Cefixime 4.8 
J01FA Macrolides J01FA01 Erythromycin 0.2 
J01FA09 Clarithromycin 6.5 
J01FA10 Azithromycin 14.7 
J01G Aminoglycoside J01GB03 Gentamicin 3.4 
J01EE Combinations of 
sulfonamides and trimethoprim 
J01EE01 Sulfamethoxazole and trimethoprim 5.3 
J01XD Imidazole derivatives J01XD01 Metronidazole 3.7 
 
Amoxicillin (19.4%), Azithromycin (14.7%), 
the combination of Amoxicillin and Clavulanic acid 
(13.5%) and Cefaclor (11.7%) were the most 
commonly prescribed. Penicillins were the most 
prescribed drugs overall, while Cephalosporins were 
more prescribed for Bronchitis, Bronchopneumonia 
and Otis. For dental infections, Penicillins remained 
the first pharmaceutical treatment choice. Macrolides 
are usually prescribed for Bronchitis and 
Bronchopneumonia.  
 
Figure 2: Prescription of Penicillins, Macrolides and Cephalosporins 
According to Diagnosis 
 
Syrups were the most commonly used 
pharmaceuticals dosage forms (53.2%), followed by 
injections (29.8%) and tablets/capsules (15%).  
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Discussions 
 
From 902 prescriptions, 64.4% were 
dispensed for children under 6 years old. In point of 
fact, the general worldwide trend is that preschool 
children are the most exposed to these drugs [4] [13]. 
Other studies have evidenced that antibiotics are 
often prescribed without likely therapeutic effects (e.g. 
for viral respiratory infections). This phenomenon is 
particularly frequent amongst children [9] [10] [14] [15] 
[16]. Most of the prescriptions in our study were for 
respiratory tract infections and bronchitis, as the most 
frequent diagnosis. According to the pediatric 
treatment recommendations of the Center for Disease 
Control and Prevention (CDCP) antibiotics are not 
helpful and should not be used for bronchitis [17]. 
Because the risk of antibiotic resistance and 
Clostridium difficile infection, antibiotics should not be 
routinely used in the treatment of acute bronchitis, 
especially in younger patients in whom pertussis is not 
suspected [18]. From this study, we discovered that 
broad spectrum abx are far more preferred 
pharmaceuticals in the Tirana region, with Penicillins 
being the most prescribed drug class, followed by 
Cephalosporines and Macrolides. Amoxicillin, 
Azithromycin, the combination of Amoxicillin and 
Clavulanic acid and Cefaclor are usually prescribed 
and dispersed for respiratory tract infection. The trend 
of using newer broad-spectrum agents in pediatric 
outpatients is spreading globally. In the Netherlands 
[13], UK [19], Italy [20], and in the US [21] [22], the 
use of broad-spectrum abx has increased 
disproportionately. The use of broad-spectrum agents 
for viral infections is also a serious concern regarding 
antibiotic resistance [23] [24]. In this study, we 
observed short duration therapies, with a mean 
duration of 5.21 days and in 17.4 % of cases with a 
duration of ≤ 2 days. This use is in contrast with 
general guidelines of antibiotic use where in most 
cases it is recommended that a therapy continues 7-
10 days for diagnosis such as Tonsillitis and 
Pneumonia [25]. Nevertheless, according to the 
pharmacokinetic characteristics of some antibiotics 
[26], and some studies in which 5 days duration 
therapies, showed that these could be equally 
effective as therapies with a duration of more than 7 
days, authors of the studies recommended to be 
cautious about the results [27]. We observed the 
widespread use of injections for outpatient children 
(almost 30% of all patients). Oral dosage of 
pharmaceutical forms is more appropriate and less 
traumatic for children. This study gives information 
about the patterns of antibiotic prescriptions in 
children for the mentioned region of Tirana. However, 
it has some limitations. First, it is limited only to 
unreimbursed prescriptions. However, a previous 
study of antibiotic consumption in Albania showed that 
the unreimbursed abx use is almost seven times 
higher than the reimbursed use [28]. Secondly, the 
location of the study is restricted to the region of 
Tirana, and this is a random sampling study. The 
absence of clinical electronic health record databases 
for drug prescription outside the reimbursement 
scheme presents a major difficulty in collecting data to 
evaluate antibiotic prescriptions for outpatients on a 
national scale. This program could help to monitor 
pharmaceuticals like antibiotics which are frequently 
prescribed and dispersed outside this scheme, 
increase the responsibilities of appropriate antibiotic 
use, including warnings, and finally, to decrease costs 
for disease management for Albanian families. 
In conclusion, this study demonstrated a large 
use of broad-spectrum antibiotics for common 
respiratory tract infection in children less than 6 years 
old. Guidelines recommend that for some of these 
infections, antibiotics can be avoided or at least 
delayed, as the situation is monitored. Short duration 
therapies were observed, raising other concerns such 
as antibiotic resistance. This study has a limited 
number of prescriptions, and it is nor conducted on a 
national scale. We would recommend the creation of 
an electronic database of patients record to monitor 
the quality of prescription and education of the health 
care professionals and patient of risks related with 
antibiotic resistance. 
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